Table of Contents
Computers in
Clinical Trials Draft Guidance - Introduction
Electronic Record
Keeping
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Electronic Records
and Signatures-The Rule
Guidance for
Industry Computerized Systems Used in Clinical
Trials DRAFT GUIDANCE This guidance
document is being distributed for comment purposes
only.
Computerized Systems
Used in Clinical Trials Working Group
Draft Guidance
Availability
Draft Guidance
Availability
Guidance
Draft Guidance
How to Comment
Draft
Guidance Scope
Draft
Guidance Scope
Draft
Guidance Contents
Draft
Guidance Contents
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Origin of Concepts
Draft
Guidance Half-time
|
Author: David
A. Lepay, MD, PhD Home Page: http://www.fda.gov/cder/present/diamontreal/
|